Abstract
Background Patients with CKD who are on hemodialysis are hyporesponsive to erythropoiesis-stimulating agents (ESAs) because of anemia of inflammation.......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
